ReviewImmunoTargets and therapy2021

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20.

Michael Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.